About this trial
The aim of the study is to assess whether the involvement of a clinical pharmacist in patient care at every stage of hospitalization, from admission to discharge, will improve the quality of healthcare services provided in clinical and economic terms. As part of the research study, we will randomly assign you to two different groups.
Within one group, a pharmacist will be involved in the process of caring for you throughout your hospital stay. The pharmacist will participate in medical rounds, verify medications upon admission to the hospital, check current test results and medical orders regarding pharmacotherapy, verify medications upon discharge and provide advice on the use of medications. All activities will be carried out in consultation with other medical staff. The aim is to check whether such a model of patient care increases safety and leads to improved pharmacotherapy for patients, and also has a positive effect on patient satisfaction and compliance with therapeutic recommendations. Additionally, the opinion of the medical staff and the economic aspects of this solution will be assessed. Within the second group, you will receive standard care offered by the hospital. In the case of both groups, after the hospitalization is completed, the pharmacist will contact you after 1, 3, 6 months to verify your health condition - he or she will ask about any hospitalizations, complications, side effects, and additional visits to the doctor.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
taking ≥4 medicines
taking high risk medicines listed in the medicines reconciliation standard of Polish Society of Clinical Pharmacy (….)
medicine related admission to the hospital within last 12 months
chronic kidney or liver disease
Disqualifiers
age below 18 years old
pregnancy
resident of long-term care facility
unable to express informed consent to participate in the research
Trial design
Parallel
Treatments tested in this trial
multidisciplinary treatment
BehavioralThe pharmacist will conduct medication reconciliation at admission, perform medication reviews during the hospital stay and provide drug education to the patient before discharge, as well as written drug information
Treatment groups
Trial outcomes
Primary outcomes
Additional episodes of care
incidence of hospital, emergency department and other unscheduled visits after discharge from hospital during the 6 months follow-up period
Secondary outcomes
LoS
the length of stay (LoS) in hospital
Other outcomes
Interventions
Evaluation of the service by determining the type of interventions performed based on classification of French Society of Clinical Pharmacy
Economy
Estimation of the potential financial benefits of the service
Patient opinion
The perception of the service by patients based on PSPSQ 2.0 questionnaire
Healthcare team opinion
The perception of the service by healthcare professionals based on questionnaire prepared by research team
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: